{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T08:17:02Z","timestamp":1772871422453,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jmirs.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Imaging and Radiation Sciences"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jmir.2024.02.009","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T15:37:08Z","timestamp":1709912228000},"page":"S39-S43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S","title":["Bone scintigraphy for cardiac amyloidosis: A Canadian perspective"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4676-2433","authenticated-orcid":false,"given":"Robert JH","family":"Miller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3356-6492","authenticated-orcid":false,"given":"Cigdem","family":"Akincioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmir.2024.02.009_bib0001","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3949\/ccjm.84.s3.02","article-title":"Cardiac amyloidosis: an update on diagnosis and treatment","volume":"84","author":"Donnelly","year":"2017","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.jmir.2024.02.009_bib0002","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.cjca.2019.12.034","article-title":"Canadian cardiovascular society\/Canadian heart failure society joint position statement on the evaluation and management of patients with cardiac amyloidosis","volume":"36","author":"Fine","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jmir.2024.02.009_bib0003","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s40119-019-0142-5","article-title":"estimating the prevalence of transthyretin amyloid cardiomyopathy in a large in-hospital database in Japan","volume":"8","author":"Winburn","year":"2019","journal-title":"Cardiol Ther"},{"key":"10.1016\/j.jmir.2024.02.009_bib0004","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005588","article-title":"Echo parameters for differential diagnosis in cardiac amyloidosis","volume":"10","author":"Pagourelias","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jmir.2024.02.009_bib0005","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcmg.2013.10.008","article-title":"Native T1 mapping in transthyretin amyloidosis","volume":"7","author":"Fontana","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jmir.2024.02.009_bib0006","article-title":"Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis","volume":"12","author":"Maurer","year":"2019","journal-title":"Circ: Heart Failure"},{"key":"10.1016\/j.jmir.2024.02.009_bib0007","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12350-019-01675-2","article-title":"Examining the sensitivity of 18F-NaF PET for the imaging of cardiac amyloidosis","volume":"28","author":"Martineau","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jmir.2024.02.009_bib0008","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jmir.2024.02.009_bib0009","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jmir.2024.02.009_bib0010","first-page":"669","article-title":"Improvement of diagnostic accuracy of Transthyretin cardiac amyloidosis (TTR-CA) with 99mTechnetium pyrophosphate SPECT imaging","volume":"60","author":"Flaherty","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jmir.2024.02.009_bib0011","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s12350-019-01718-8","article-title":"Straightening out the wrinkles in technetium-99m-labeled bone scintigraphy tracer assessment of cardiac amyloidosis","volume":"28","author":"Small","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jmir.2024.02.009_bib0012","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1007\/s12350-020-02139-8","article-title":"Technetium pyrophosphate nuclear scintigraphy for cardiac amyloidosis: imaging at 1vs 3 h and planar vs SPECT\/CT","volume":"27","author":"Sperry","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jmir.2024.02.009_bib0013","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1007\/s12350-023-03297-1","article-title":"Diagnostic accuracy of bone scintigraphy imaging for transthyretin cardiac amyloidosis: systematic review and meta-analysis","volume":"30","author":"Ahluwalia","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jmir.2024.02.009_bib0014","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.jcmg.2023.01.018","article-title":"Can deep learning detect incidental abnormal cardiac uptake related to amyloidosis on routine bone scintigraphy?","volume":"16","author":"Slomka","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jmir.2024.02.009_bib0015","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cardfail.2021.06.012","article-title":"Addendum to ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2-evidence base and standardized methods of imaging","volume":"28","author":"Dorbala","year":"2022","journal-title":"j card fail"},{"key":"10.1016\/j.jmir.2024.02.009_bib0016","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s12350-022-03133-y","article-title":"Tc-PYP SPECT and SPECT\/CT quantitation for diagnosing cardiac transthyretin amyloidosis","volume":"30","author":"Nichols","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jmir.2024.02.009_bib0017","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s12350-022-02985-8","article-title":"Hot spot imaging in cardiovascular diseases: an information statement from SNMMI, ASNC, and EANM","volume":"30","author":"Sperry","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jmir.2024.02.009_bib0018","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1007\/s12350-023-03256-w","article-title":"Comparison of cardio-focal and chest reconstruction of technetium-99m pyrophosphate scintigraphy for diagnosis of transthyretin cardiac amyloidosis: a quality assurance study","volume":"30","author":"Akincioglu","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jmir.2024.02.009_bib0019","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jcmg.2017.06.020","article-title":"Regional variation in technetium pyrophosphate uptake in transthyretin cardiac amyloidosis and impact on mortality","volume":"11","author":"Sperry","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jmir.2024.02.009_bib0020","article-title":"Association between atrial uptake on cardiac scintigraphy with technetium-99m-pyrophosphate labeled bone-seeking tracers and atrial fibrillation","volume":"15","author":"Hussain","year":"2022","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jmir.2024.02.009_bib0021","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1007\/s12350-020-02508-3","article-title":"Tc-99m pyrophosphate left atrial uptake in patients with atrial fibrillation and cardiac amyloidosis","volume":"29","author":"Abazid","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jmir.2024.02.009_bib0022","first-page":"3362","article-title":"99mTc-pyrophosphate right ventricular myocardial uptake in ATTR","volume":"63","author":"Palestro","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jmir.2024.02.009_bib0023","doi-asserted-by":"crossref","first-page":"652","DOI":"10.2967\/jnumed.122.264423","article-title":"Deep learning coronary artery calcium scores from SPECT\/CT attenuation maps improve prediction of major adverse cardiac events","volume":"64","author":"Miller","year":"2023","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jmir.2024.02.009_bib0024","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12350-018-01552-4","article-title":"State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis","volume":"26","author":"Singh","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jmir.2024.02.009_bib0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s41824-018-0035-1","article-title":"Tc-HDP quantitative SPECT\/CT in transthyretin cardiac amyloid and the development of a reference interval for myocardial uptake in the non-affected population","volume":"2","author":"Ramsay","year":"2018","journal-title":"Eur J Hybrid Imaging"},{"key":"10.1016\/j.jmir.2024.02.009_bib0026","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s12350-021-02563-4","article-title":"Diagnostic and prognostic value of technetium-99m pyrophosphate uptake quantitation for transthyretin cardiac amyloidosis","volume":"28","author":"Miller","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jmir.2024.02.009_bib0027","doi-asserted-by":"crossref","first-page":"716","DOI":"10.2967\/jnumed.120.247312","article-title":"Absolute quantitation of cardiac 99mTc-pyrophophate using cadmium zinc telluride-based SPECT\/CT","volume":"62","author":"Dorbala","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jmir.2024.02.009_bib0028","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40658-020-00342-7","article-title":"Assessment of cardiac amyloidosis with (99m)Tc-pyrophosphate (PYP) quantitative SPECT","volume":"8","author":"Ren","year":"2021","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.jmir.2024.02.009_bib0029","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1007\/s12350-021-02806-4","article-title":"Quantitative cardiovascular magnetic resonance and technetium pyrophosphate imaging in patients with suspected cardiac amyloidosis","volume":"29","author":"Roshankar","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jmir.2024.02.009_bib0030","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.122.014954","article-title":"Complete resolution of technetium pyrophosphate uptake after treatment of transthyretin cardiac amyloidosis","volume":"16","author":"Sperry","year":"2023","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jmir.2024.02.009_bib0031","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jcmg.2020.07.043","article-title":"Reduction in CMR derived extracellular volume with patisiran indicates cardiac amyloid regression","volume":"14","author":"Fontana","year":"2021","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["Journal of Medical Imaging and Radiation Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939865424000225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939865424000225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T14:48:31Z","timestamp":1716648511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939865424000225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1939865424000225"],"URL":"https:\/\/doi.org\/10.1016\/j.jmir.2024.02.009","relation":{},"ISSN":["1939-8654"],"issn-type":[{"value":"1939-8654","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone scintigraphy for cardiac amyloidosis: A Canadian perspective","name":"articletitle","label":"Article Title"},{"value":"Journal of Medical Imaging and Radiation Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmir.2024.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of Canadian Association of Medical Radiation Technologists.","name":"copyright","label":"Copyright"}]}}